Intermediates for macrocyclic compounds

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9181298
APP PUB NO 20090240027A1
SERIAL NO

12273638

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to novel macrocyclic compounds of formula (I) and their pharmaceutically acceptable salts, hydrates or solvates:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
OCERA THERAPEUTICS INC525 UNIVERSITY AVENUE STE 610 PALO ALTO CA 94301-1920

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Beaubien, Sylvie Sherbrooke, CA 13 180
Beauchemin, Sophie Sherbrooke, CA 10 100
Benakli, Kamel Blue Bell, US 12 154
Hoveyda, Hamid Brussels, BE 29 186
Marsault, Eric Sherbrooke, CA 40 487
Oullet, Luc Sherbrooke, CA 3 0
Peterson, Mark Sherbrooke, CA 182 5031
St-Louis, Carl Sherbrooke, CA 9 74

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 10, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00